TRILACICLIB

Clinical trials for TRILACICLIB explained in plain language.

Never miss a new study

Get alerted when new TRILACICLIB trials appear

Sign up with your email to follow new studies for TRILACICLIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug aims to shield patients from Chemo's harsh side effects

Disease control Recruiting now

This study is testing whether a drug called trilaciclib can protect patients' bone marrow from damage during chemotherapy for solid tumors. Researchers will enroll 100 patients to see if the drug reduces severe blood cell drops, which are common and dangerous side effects of canc…

Matched conditions: TRILACICLIB

Phase: PHASE1 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

TRILACICLIB

Get alerted when new TRILACICLIB trials appear

New drug aims to shield patients from Chemo's harsh side effects